Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science. The company focuses on developing precision medicines for kidney diseases. Its services offers utilization of novel translational platforms and patient stratification tools, and emergence of accelerated regulatory pathways based on surrogate endpoints.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Chinook Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Chinook Therapeutics Inc market cap is $2.9B.
What is the 52-week high for Chinook Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Chinook Therapeutics Inc 52 week high is $40.51 as of September 29, 2025.
What is the 52-week low for Chinook Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Chinook Therapeutics Inc 52 week low is $18.34 as of September 29, 2025.
What is Chinook Therapeutics Inc stock price today?
Chinook Therapeutics Inc stock price today is $40.39.
What was Chinook Therapeutics Inc stock price yesterday?
Chinook Therapeutics Inc stock price yesterday was $40.30.
What is the PE ratio of Chinook Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Chinook Therapeutics Inc’s P/E ratio is -11.49.
What is the Price-to-Book ratio of Chinook Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Chinook Therapeutics Inc P/B ratio is 7.5883.
What is Chinook Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Chinook Therapeutics Inc's EBITDA is -11.21.
What is the 50-day moving average of Chinook Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Chinook Therapeutics Inc 50-day moving average is $38.59.